Law360, New York (May 22, 2012, 7:39 PM ET) -- Drug industry stakeholders and lawmakers have yet to come to a final agreement on a nationwide system for tracking pharmaceuticals, but said Tuesday that they expect to reach a deal in time to include it in the U.S. Food and Drug Administration user fee bill.
The track-and-trace proposal, developed by a range of industry stakeholders, is a major piece of unfinished business in the user fee bill. On Monday, Senate health committee leaders filed a final version on the bill, which leaders hope to vote on...
No Deal Yet On National Drug Track-And-Trace System
To view the full article, take a free trial now.
